

Search

EN

Back



Edgen - healthcare : biotech

healthcare: biotechNews

For you Markets Economy Tech & AI Crypto Energy Healthcare HK & China Finance

Pharma

Biotech

Health Services

Medical Devices

Nanobiotix Posts 57% Complete Response in Phase 2 Lung Cancer Study

Nanobiotix Posts 57% Complete Response in Phase 2 Lung Cancer Study

May 17 2026, 14:47

ImmunityBio Tackles 10-Year Cancer Drug Shortage With New Japan Deal

ImmunityBio Tackles 10-Year Cancer Drug Shortage With New Japan Deal

May 16 2026, 18:17

Moleculin reports 40% remission rate in AML trial but cash runs short

Moleculin reports 40% remission rate in AML trial but cash runs short

May 15 2026, 12:52

Inmune Bio Rises 10% as Alzheimer's Drug Succeeds in Phase 2

Inmune Bio Rises 10% as Alzheimer's Drug Succeeds in Phase 2

May 15 2026, 12:21

Sensei Bio pivots to PI3K, ends Q1 with $203M after Faeth deal

Sensei Bio pivots to PI3K, ends Q1 with $203M after Faeth deal

May 15 2026, 11:48

Protara Posts 55% 12-Month Bladder Cancer Response Rate

Protara Posts 55% 12-Month Bladder Cancer Response Rate

May 15 2026, 11:20

CG Oncology Eyes 2x Market Expansion With Bladder Cancer BLA on Track for Q4

CG Oncology Eyes 2x Market Expansion With Bladder Cancer BLA on Track for Q4

May 15 2026, 07:45

Esperion to Detail New Bempedoic Acid Data After $1.1B Buyout

Esperion to Detail New Bempedoic Acid Data After $1.1B Buyout

May 14 2026, 16:24

Senti Bio Secures $40 Million, Advances Cancer Therapy to Pivotal Trial

Senti Bio Secures $40 Million, Advances Cancer Therapy to Pivotal Trial

May 14 2026, 13:16

Celcuity Expands Gedatolisib Trial to 90,000 Patients in First-Line Breast Cancer

Celcuity Expands Gedatolisib Trial to 90,000 Patients in First-Line Breast Cancer

May 14 2026, 12:15

Ionis Jumps 8% as Alzheimer's Drug Is First to Show Cognitive Gain

Ionis Jumps 8% as Alzheimer's Drug Is First to Show Cognitive Gain

May 14 2026, 11:48

Cabaletta posts 50% response rate in PC-free CAR-T study

Cabaletta posts 50% response rate in PC-free CAR-T study

May 14 2026, 11:41

Regenxbio Gene Therapy Hits 93% Expression in Trial, Challenging Rival

Regenxbio Gene Therapy Hits 93% Expression in Trial, Challenging Rival

May 14 2026, 11:41

Cellectar secures $140 million to advance pivotal cancer therapy

Cellectar secures $140 million to advance pivotal cancer therapy

May 14 2026, 11:40

Invivyd loss widens to $41M as trial costs mount despite 22% revenue growth

Invivyd loss widens to $41M as trial costs mount despite 22% revenue growth

May 14 2026, 11:12

Revolution Medicines Drug Doubles Survival in 90% of Pancreatic Cancers

Revolution Medicines Drug Doubles Survival in 90% of Pancreatic Cancers

May 14 2026, 10:47

Wall Street bets on 1 new cancer test to predict recurrence

Wall Street bets on 1 new cancer test to predict recurrence

May 14 2026, 10:10

Arrowhead Targets $4 Billion Drug Market as Key Pipeline Readouts Near

Arrowhead Targets $4 Billion Drug Market as Key Pipeline Readouts Near

May 14 2026, 09:41

Immunic secures $200 million to advance phase 3 MS drug trial

Immunic secures $200 million to advance phase 3 MS drug trial

May 13 2026, 13:49

Voyager Surges After Positive 3-Month Alzheimer's Gene Therapy Data

Voyager Surges After Positive 3-Month Alzheimer's Gene Therapy Data

May 13 2026, 10:11

Features

AI Copilot for Stock & Crypto

Price Prediction

Fundraise Tracker

Crypto Comparison

Markets

News

AI & Technology

Terms of Use Privacy Policy Sitemap

© 2026 Edgen Powered by